Clinical baseline factors predict response to natalizumab: their usefulness in patient selection

Background: Optimal patient selection would improve the risk-benefit ratio of natalizumab http://t.co/2ypNtEUu4h

via VAT ENGPlus Combo | VATPlus | MotionTrak http://t.co/2ypNtEUu4h